Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study

OBJECTIVES: Mycophenolate mofetil (MMF) is the standard treatment for lupus nephritis. In Japan, it was approved for lupus nephritis in 2015. We investigated its real-world safety and effectiveness in Japanese patients with systemic lupus erythematosus (SLE). METHODS: We analyzed the continuation ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Yoshiyuki, Tada, Kurisu, Yamaji, Ken, Tamura, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850850/
https://www.ncbi.nlm.nih.gov/pubmed/33564682
http://dx.doi.org/10.1155/2021/8630596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850850/
https://www.ncbi.nlm.nih.gov/pubmed/33564682
http://dx.doi.org/10.1155/2021/8630596

Ejemplares similares